Electra Private Equity PLC Board Appointment (5184P)
18 November 2016 - 6:01PM
UK Regulatory
TIDMELTA
RNS Number : 5184P
Electra Private Equity PLC
18 November 2016
ELECTRA PRIVATE EQUITY PLC
18 November 2016
Board Appointment
The Board of Electra Private Equity PLC ("the Company") is
pleased to announce the appointment of two non-executive directors
of the Company: Linda Wilding with effect from 1 December 2016 and
John McAdam with effect from 1 January 2017. Dr McAdam will also be
appointed as the Senior Independent Director.
Linda Wilding has extensive experience in the private equity
investment and healthcare sectors. Having qualified as a chartered
accountant with Ernst & Young, she worked in the private equity
division of Mercury Asset Management from 1989 to 2001, rising to
the position of Managing Director. She has served as a
non-executive director (including as Chairman) on the boards of a
number of companies. She is currently a non-executive director of
Imperial Innovations Group plc and UDG Healthcare plc. She is
currently Chairman of the HgCapital Private Equity Valuation
Committee, from which she intends to stand down in January 2017.
She was a non-executive director and latterly Chair of Corin plc
from 2006 to 2012. She has not held any other directorships of
publicly quoted companies in the last five years.
John McAdam has extensive experience of senior leadership of
global businesses in a wide range of industry sectors gained from
his career with ICI and Unilever over more than 30 years and his
other Board and advisor appointments. John joined Unilever PLC as a
management trainee in 1974 and went on to hold a number of senior
positions in Birds Eye Walls, Quest and Unichema before joining ICI
plc, where he was Chief Executive until 2007. He is Chairman of
Rentokil Initial plc and United Utilities plc and also a
Non-Executive Director of Rolls-Royce Group plc. He was Senior
Independent Director of J Sainsbury PLC until July 2016 and a
Non-Executive Director of Sara Lee Corp (2008-14) and Severn Trent
plc (2000-05). He has not held any other directorships of publicly
quoted companies in the last five years.
There is no other information concerning Dr Wilding or Dr McAdam
which is required to be disclosed pursuant to paragraph 9.6.13 R of
the Listing Rules.
Neil Johnson, Chairman of Electra Private Equity, said:
"We are delighted that Linda Wilding and John McAdam will be
joining the Electra Board. Linda brings a wealth of experience, in
particular in the listed private equity sector. John's extensive
career at a range of global companies will bring valuable
industrial expertise to the board as we pursue our strategy of
enhancing shareholder value. Both Linda and John are experienced
and high-calibre individuals and they will make an immense
contribution to the Board."
- ENDS -
For further information please contact:
Gill Ackers/Kim Fletcher
Brunswick Group LLP
020 7404 5959
Electra@brunswickgroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAZMMMMLNKGVZM
(END) Dow Jones Newswires
November 18, 2016 02:01 ET (07:01 GMT)
Unbound (LSE:UBG)
Historical Stock Chart
From Apr 2024 to May 2024
Unbound (LSE:UBG)
Historical Stock Chart
From May 2023 to May 2024